Optical coherence tomography guided drug coated balloon in the treatment of in situ lesions in young patients with coronary heart disease

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000041125

Enrollment

Unknown

Registered

2020-12-19

Start date

2021-01-01

Completion date

Unknown

Last updated

2022-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

1:DES

2:DCB

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged between 18 and 45 years; 2. Patients with single vessel disease requiring PCI; 3. Reference vessel diameter is less than 2.8mm; 4. Written informed consent provided.

Exclusion criteria

Exclusion criteria: 1. Patients with acute myocardial infarction; 2. Patients with left ventricular dysfunction; 3. Patients with left main artery disease; 4. Patients with bifurcation lesions; 5. Patients with in stent restenosis; 6. Patients with anticoagulation contraindications.

Design outcomes

Primary

Measure	Time frame
LLL;	—

Secondary

Measure	Time frame
neointimal characteristics;in-segment maximal area stenosis;target lesion failure rate;	—

Countries

China

Contacts

Public ContactXiantao Song

Internal Medicine-Cardiovascular Department, Beijing Anzhen Hospital Affiliated to Capital Medical University

songxiantao0929@qq.com+86 13910816204

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026